Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2923 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-05-09 | 2024-09-19 | 227474 |
| TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2025-08-08 | 2025-10-02 | 264792 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273234 |
| TEVA-CARVEDILOL | 6.25MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273237 |
| TEVA-CARVEDILOL | 12.5MG | TABLET | Actual shortage | 2025-12-04 | 2025-12-04 | 273240 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2019-11-21 | 2020-01-30 | 99426 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-09 | 190716 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-06-26 | 2024-01-11 | 196406 |
| TEVA-CEFADROXIL | 500MG | CAPSULE | Actual shortage | 2025-11-27 | 2025-12-11 | 272754 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2019-06-27 | 2019-07-16 | 87693 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2019-10-10 | 2019-11-28 | 96076 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2020-01-17 | 2020-04-02 | 103572 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-01-24 | 2020-04-09 | 104356 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-03-12 | 2020-04-02 | 108590 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-04 | 113767 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124980 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128013 |
| TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2021-02-25 | 2021-03-04 | 134733 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |